Results 131 to 140 of about 6,434 (171)
Marker-to-Object Calibration Using Landmark Touch. [PDF]
Ai L, Sengupta S, Chen Y.
europepmc +1 more source
Hypergravity Enhances Stretch Sensitivity in Rat Cardiomyocytes via Increased Expression and Activity of Stretch-Activated Channels. [PDF]
Kamkin AG +8 more
europepmc +1 more source
Socio-demographic factors influencing obesity among ever-married Jordanian women of reproductive age: insights from the 2023 Jordan demographic and health survey. [PDF]
Ibrahim AAA +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
ISAC-II : a project for higher energies at ISAC
PACS2001. Proceedings of the 2001 Particle Accelerator Conference (Cat. No.01CH37268), 2015In the field of nuclear physics it is generally acknowledged that a new frontier will be probed when radioactive ion beams of sufficient intensity and quality become available. With the ISAC facility, TRIUMF has positioned itself as offering the best possible source of exotic beams in the world for many years to come.
TRIUMF-ISAC Facility, Towner, I.
+4 more sources
Hyperfine Interactions, 2013
TRIUMF operates the rare ion beam facility ISAC, which provides intense beams of short lived isotopes in the energy range from 0.15 to 5 A MeV for A < 30 to a full suite of world class experimental apparatus, enabling a forefront research program focused on understanding the evolution of nuclear structure towards the limits of existence, the origin of ...
J. Dilling, R. Krücken, G. Ball
openaire +1 more source
TRIUMF operates the rare ion beam facility ISAC, which provides intense beams of short lived isotopes in the energy range from 0.15 to 5 A MeV for A < 30 to a full suite of world class experimental apparatus, enabling a forefront research program focused on understanding the evolution of nuclear structure towards the limits of existence, the origin of ...
J. Dilling, R. Krücken, G. Ball
openaire +1 more source
Nature Cancer, 2020
Immunostimulatory agents such as Toll-like receptor (TLR) agonists have shown promising antitumor efficacy but are associated with therapy-related toxicities when delivered systemically. Immune-stimulating antibody conjugates are now shown to deliver TLR agonists with potent preclinical antitumor activities.
Demaria, Olivier, Vivier, Eric
openaire +3 more sources
Immunostimulatory agents such as Toll-like receptor (TLR) agonists have shown promising antitumor efficacy but are associated with therapy-related toxicities when delivered systemically. Immune-stimulating antibody conjugates are now shown to deliver TLR agonists with potent preclinical antitumor activities.
Demaria, Olivier, Vivier, Eric
openaire +3 more sources
Hyperfine Interactions, 2013
The TRIUMF-ISAC radioactive ion beam facility was designed and constructed to allow irradiation of thick targets with up to 100 \(\upmu \)A proton beam intensities. Since beginning operation in 1998, beam intensities on ISAC targets have progressively increased toward the 100 \(\upmu \)A design limit.
M. Dombsky, P. Kunz
openaire +1 more source
The TRIUMF-ISAC radioactive ion beam facility was designed and constructed to allow irradiation of thick targets with up to 100 \(\upmu \)A proton beam intensities. Since beginning operation in 1998, beam intensities on ISAC targets have progressively increased toward the 100 \(\upmu \)A design limit.
M. Dombsky, P. Kunz
openaire +1 more source
The eighth international conference on heavy-ion accelerator technology, 1999
Construction has begun on ISAC, a radioactive ion beam (RIB) and accelerator facility that utilizes the ISOL (on-line isotope separation) production method. A five-year budget for this new radioactive beam facility at TRIUMF was approved in June 1995.
openaire +1 more source
Construction has begun on ISAC, a radioactive ion beam (RIB) and accelerator facility that utilizes the ISOL (on-line isotope separation) production method. A five-year budget for this new radioactive beam facility at TRIUMF was approved in June 1995.
openaire +1 more source

